webinar register page

Webinar banner
ITM Alumni webinar - Integrated control of skin NTDs in Ethiopia: Concepts and potential synergies in the realm of resource limitation
Neglected tropical diseases (NTDs) threaten more than 1.7 billion people living in the poorest and most marginalized communities worldwide. Within the cluster of NTDs, many of the diseases involve the skin, either as the primary presentation or as a related clinical feature. The skin NTDs often present with disfigurement, limb deformity, elephantiasis/hydrocele, physical disability, stigmatization, discrimination, and psycho-social suffering. Moreover, these skin changes can result in stigmatization, discrimination, and psychosocial distress.
To address those challenges WHO promotes integrated and community-based approaches to control skin NTDs. Early identification of skin NTDs is hindered by the lack of knowledge about these conditions. To this end developing simplified training tools, capacitating primary health workers and decentralising the diagnosis and management of the most common skin NTDs is important.
Decentralising skin NTDs from specialised centers to the primary health system structure and to community-based management is a task-shifting that can improve timely access to care and cost inconvenience of visiting busy health facilities. And from a health system perspective, it will help specialised hospitals to dedicate their precious resources to addressing other conditions that require higher levels of clinical expertise.

In light of World NTD Day, ITM alumnus Wendemagegn Enbiale Yeshaneh will share his research findings on the integrated control of skin NTDs in Ethiopia. He will explore concepts and potential synergies in the realm of resource limitation. While focusing on the dermatological manifestation of NTDs in Ethiopia (from a more clinical perspective), Wende will also share his thoughts on the challenges related to treatment and prevention measures.

The Q&A-session will be moderated by Dr Johan van Griensven, head of the NTD-unit at the ITM Clinical Sciences Department.

Jan 30, 2023 01:00 PM in Brussels

Webinar logo
* Required information


Wendemagegn Enbiale Yeshaneh
Professor of Dermatovenerology @Bahir Dar University, Ethiopia
Prof. Wendemagegn is a medical doctor by training and trained as specialist in Dermatovenerology from Addis Ababa University, Ethiopia. He has a Master's in Public Health from Manchester Metropolitan University and a Ph.D. from University of Amsterdam. He has been involved in outbreak management, community-based research, operational research, and clinical trials and he has authored and co-authored about 38 papers published in peer-reviewed journals (focused on NTDs) and book chapters. He is an advisory council for the International Alliance for the Control of Scabies (IACS), International Alliance for Global Health Dermatology (GLODERM) and Amref Ethiopia. He is also serving as a WHO Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTDs) and vice-chair of the national NTD Research Advisory Committee for the Ethiopian Ministry of Health (MOH).
Johan van Griensven
head NTD-unit, Clinical Sciences Department, @ITM, Antwerp
Prof. Dr. Johan van Griensven graduated with a medical degree from the Catholic University of Leuven (Belgium) and trained as a specialist in internal medicine in Leuven and South Africa. In 2004, he completed his PhD as a FWO fellow at the Laboratory of Molecular Medicine and Virology at the Rega institute (Leuven, Belgium). He also obtained a MSc in Epidemiology from the University of London/LSHTM. He is currently professor in ‘Neglected Tropical Diseases (NTDs)’ and works at ITM since 2008. He has previously worked and lived as a clinician and researcher in Botswana (2004-2005), Rwanda (2005- 2008) and Cambodia (2010-2014). He was the coordinator of a large consortium on convalescent plasma treatment in the Ebola virus outbreak in 2013 (http://www.ebolatx.eu/). In 2015, he founded and still heads the NTD unit at the Clinical Sciences Department, with the aim to develop a clinical and immunological research line on leishmaniasis and other NTDs.